Toward a model informed consent process for BRCA1 testing: A qualitative assessment of women's attitudes

Barbara A. Bernhardt, Gail Geller, Misha Strauss, Kathy J. Helzlsouer, Michael Edward Stefanek, Patti M. Wilcox, Neil A. Holtzman

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

As an initial part of a project to develop a model informed consent process for BRCA1 testing, we conducted a series of focus groups. At the groups, women initially expressed great interest in testing, but their interest diminished after learning more. If offered testing, women would most want to learn about test accuracy, practical details of testing, and management options if the result was positive. Perceived benefits of testing included gaining information leading to risk reduction, relief of uncertainty, more responsible parenting, and assisting in research. Perceived risks included the discomfort and cost of the testing process itself, and anxiety after a positive result. The risk of possible insurance discrimination was rarely mentioned spontaneously. Many women would want their providers to make recommendations, rather than be nondirective about testing. We observed that women vary greatly in their informational and counseling needs, and suggest that the informed consent process should be individualized, taking into account a woman's perception and her preferences for how testing decisions should be made.

Original languageEnglish (US)
Pages (from-to)207-222
Number of pages16
JournalJournal of Genetic Counseling
Volume6
Issue number2
DOIs
StatePublished - Jan 1 1997
Externally publishedYes

Fingerprint

Informed Consent
Parenting
Risk Reduction Behavior
Insurance
Focus Groups
Uncertainty
Counseling
Anxiety
Learning
Costs and Cost Analysis
Research

Keywords

  • Breast cancer
  • Genetic testing
  • Informed consent
  • Patient decision-making

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Bernhardt, B. A., Geller, G., Strauss, M., Helzlsouer, K. J., Stefanek, M. E., Wilcox, P. M., & Holtzman, N. A. (1997). Toward a model informed consent process for BRCA1 testing: A qualitative assessment of women's attitudes. Journal of Genetic Counseling, 6(2), 207-222. https://doi.org/10.1023/A:1025668320403

Toward a model informed consent process for BRCA1 testing : A qualitative assessment of women's attitudes. / Bernhardt, Barbara A.; Geller, Gail; Strauss, Misha; Helzlsouer, Kathy J.; Stefanek, Michael Edward; Wilcox, Patti M.; Holtzman, Neil A.

In: Journal of Genetic Counseling, Vol. 6, No. 2, 01.01.1997, p. 207-222.

Research output: Contribution to journalArticle

Bernhardt, BA, Geller, G, Strauss, M, Helzlsouer, KJ, Stefanek, ME, Wilcox, PM & Holtzman, NA 1997, 'Toward a model informed consent process for BRCA1 testing: A qualitative assessment of women's attitudes', Journal of Genetic Counseling, vol. 6, no. 2, pp. 207-222. https://doi.org/10.1023/A:1025668320403
Bernhardt, Barbara A. ; Geller, Gail ; Strauss, Misha ; Helzlsouer, Kathy J. ; Stefanek, Michael Edward ; Wilcox, Patti M. ; Holtzman, Neil A. / Toward a model informed consent process for BRCA1 testing : A qualitative assessment of women's attitudes. In: Journal of Genetic Counseling. 1997 ; Vol. 6, No. 2. pp. 207-222.
@article{8148c209415f4687b6c5a139d5ee8cb6,
title = "Toward a model informed consent process for BRCA1 testing: A qualitative assessment of women's attitudes",
abstract = "As an initial part of a project to develop a model informed consent process for BRCA1 testing, we conducted a series of focus groups. At the groups, women initially expressed great interest in testing, but their interest diminished after learning more. If offered testing, women would most want to learn about test accuracy, practical details of testing, and management options if the result was positive. Perceived benefits of testing included gaining information leading to risk reduction, relief of uncertainty, more responsible parenting, and assisting in research. Perceived risks included the discomfort and cost of the testing process itself, and anxiety after a positive result. The risk of possible insurance discrimination was rarely mentioned spontaneously. Many women would want their providers to make recommendations, rather than be nondirective about testing. We observed that women vary greatly in their informational and counseling needs, and suggest that the informed consent process should be individualized, taking into account a woman's perception and her preferences for how testing decisions should be made.",
keywords = "Breast cancer, Genetic testing, Informed consent, Patient decision-making",
author = "Bernhardt, {Barbara A.} and Gail Geller and Misha Strauss and Helzlsouer, {Kathy J.} and Stefanek, {Michael Edward} and Wilcox, {Patti M.} and Holtzman, {Neil A.}",
year = "1997",
month = "1",
day = "1",
doi = "10.1023/A:1025668320403",
language = "English (US)",
volume = "6",
pages = "207--222",
journal = "Journal of Genetic Counseling",
issn = "1059-7700",
publisher = "Kluwer Academic/Human Sciences Press Inc.",
number = "2",

}

TY - JOUR

T1 - Toward a model informed consent process for BRCA1 testing

T2 - A qualitative assessment of women's attitudes

AU - Bernhardt, Barbara A.

AU - Geller, Gail

AU - Strauss, Misha

AU - Helzlsouer, Kathy J.

AU - Stefanek, Michael Edward

AU - Wilcox, Patti M.

AU - Holtzman, Neil A.

PY - 1997/1/1

Y1 - 1997/1/1

N2 - As an initial part of a project to develop a model informed consent process for BRCA1 testing, we conducted a series of focus groups. At the groups, women initially expressed great interest in testing, but their interest diminished after learning more. If offered testing, women would most want to learn about test accuracy, practical details of testing, and management options if the result was positive. Perceived benefits of testing included gaining information leading to risk reduction, relief of uncertainty, more responsible parenting, and assisting in research. Perceived risks included the discomfort and cost of the testing process itself, and anxiety after a positive result. The risk of possible insurance discrimination was rarely mentioned spontaneously. Many women would want their providers to make recommendations, rather than be nondirective about testing. We observed that women vary greatly in their informational and counseling needs, and suggest that the informed consent process should be individualized, taking into account a woman's perception and her preferences for how testing decisions should be made.

AB - As an initial part of a project to develop a model informed consent process for BRCA1 testing, we conducted a series of focus groups. At the groups, women initially expressed great interest in testing, but their interest diminished after learning more. If offered testing, women would most want to learn about test accuracy, practical details of testing, and management options if the result was positive. Perceived benefits of testing included gaining information leading to risk reduction, relief of uncertainty, more responsible parenting, and assisting in research. Perceived risks included the discomfort and cost of the testing process itself, and anxiety after a positive result. The risk of possible insurance discrimination was rarely mentioned spontaneously. Many women would want their providers to make recommendations, rather than be nondirective about testing. We observed that women vary greatly in their informational and counseling needs, and suggest that the informed consent process should be individualized, taking into account a woman's perception and her preferences for how testing decisions should be made.

KW - Breast cancer

KW - Genetic testing

KW - Informed consent

KW - Patient decision-making

UR - http://www.scopus.com/inward/record.url?scp=0031151757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031151757&partnerID=8YFLogxK

U2 - 10.1023/A:1025668320403

DO - 10.1023/A:1025668320403

M3 - Article

C2 - 11656642

AN - SCOPUS:0031151757

VL - 6

SP - 207

EP - 222

JO - Journal of Genetic Counseling

JF - Journal of Genetic Counseling

SN - 1059-7700

IS - 2

ER -